prnewswire.comAMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs7 days ago
prnewswire.comAMI Pharm Advances AYP-101 to Phase 3, Redefining Fat-Reduction Injectable drug with Patient Comfort in Focus7 days ago
prnewswire.comInnovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer7 months ago
businesswire.comNewron and Myung In Pharm Announce License Agreement for evenamide in South Korea7 months ago
businesswire.comNewron and Myung In Pharm Announce License Agreement for evenamide in South Korea7 months ago
businesswire.comTetra Pharm Technologies Prescribes Rootstock ERP to Drive Its Digital Strategy9 months ago
businesswire.comTetra Pharm Technologies Prescribes Rootstock ERP to Drive Its Digital Strategy9 months ago